These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 20083731

  • 1. Amino-terminal pro-B-type natriuretic peptide improves cardiovascular and cerebrovascular risk prediction in the population: the Rotterdam study.
    Rutten JH, Mattace-Raso FU, Steyerberg EW, Lindemans J, Hofman A, Wieberdink RG, Breteler MM, Witteman JC, van den Meiracker AH.
    Hypertension; 2010 Mar; 55(3):785-91. PubMed ID: 20083731
    [Abstract] [Full Text] [Related]

  • 2. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
    Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, Hildebrandt P.
    JAMA; 2005 Apr 06; 293(13):1609-16. PubMed ID: 15811980
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
    Skoglund PH, Arpegård J, Ostergren J, Svensson P.
    Am J Hypertens; 2014 Mar 06; 27(3):363-71. PubMed ID: 24470529
    [Abstract] [Full Text] [Related]

  • 5. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
    Roldán V, Vílchez JA, Manzano-Fernández S, Jover E, Gálvez J, Puche CM, Valdés M, Vicente V, Lip GY, Marín F.
    Stroke; 2014 Mar 06; 45(3):696-701. PubMed ID: 24519407
    [Abstract] [Full Text] [Related]

  • 6. Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease.
    Ahluwalia N, Blacher J, Szabo de Edelenyi F, Faure P, Julia C, Hercberg S, Galan P.
    Atherosclerosis; 2013 Jun 06; 228(2):478-84. PubMed ID: 23582589
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in a Japanese community: the Hisayama study.
    Doi Y, Ninomiya T, Hata J, Hirakawa Y, Mukai N, Ikeda F, Fukuhara M, Iwase M, Kiyohara Y.
    Arterioscler Thromb Vasc Biol; 2011 Dec 06; 31(12):2997-3003. PubMed ID: 21921261
    [Abstract] [Full Text] [Related]

  • 9. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
    Wolsk E, Claggett B, Pfeffer MA, Diaz R, Dickstein K, Gerstein HC, Lawson FC, Lewis EF, Maggioni AP, McMurray JJV, Probstfield JL, Riddle MC, Solomon SD, Tardif JC, Køber L.
    J Am Heart Assoc; 2017 May 29; 6(6):. PubMed ID: 28554908
    [Abstract] [Full Text] [Related]

  • 10. Increase in N-terminal pro-brain natriuretic peptide levels, renal function and cardiac disease in the oldest old.
    Poortvliet R, de Craen A, Gussekloo J, de Ruijter W.
    Age Ageing; 2015 Sep 29; 44(5):841-7. PubMed ID: 26209786
    [Abstract] [Full Text] [Related]

  • 11. The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population.
    Zhu Q, Xiao W, Bai Y, Ye P, Luo L, Gao P, Wu H, Bai J.
    Clin Interv Aging; 2016 Sep 29; 11():245-53. PubMed ID: 27013868
    [Abstract] [Full Text] [Related]

  • 12. Amino-Terminal Pro-B-Type Natriuretic Peptide Improves Discrimination for Incident Atherosclerotic Cardiovascular Disease Beyond Ambulatory Blood Pressure in Elderly Men.
    Skoglund PH, Höijer J, Ärnlöv J, Zethelius B, Svensson P.
    Hypertension; 2015 Sep 29; 66(3):681-6; discussion 445. PubMed ID: 26150437
    [Abstract] [Full Text] [Related]

  • 13. Serial measurements of N-terminal pro-brain natriuretic peptide in patients with coronary heart disease.
    Dallmeier D, Pencina MJ, Rajman I, Koenig W, Rothenbacher D, Brenner H.
    PLoS One; 2015 Sep 29; 10(1):e0117143. PubMed ID: 25629613
    [Abstract] [Full Text] [Related]

  • 14. Prognostic value of midregional pro-A-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in patients with stable coronary heart disease followed over 8 years.
    Karakas M, Jaensch A, Breitling LP, Brenner H, Koenig W, Rothenbacher D.
    Clin Chem; 2014 Nov 29; 60(11):1441-9. PubMed ID: 25139456
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prognostic usefulness of the change in N-terminal pro B-type natriuretic peptide levels to predict mortality in a single community cohort aged ≥ 70 years.
    Eggers KM, Venge P, Lind L.
    Am J Cardiol; 2013 Jan 01; 111(1):131-6. PubMed ID: 23040598
    [Abstract] [Full Text] [Related]

  • 17. A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score.
    Salah K, Kok WE, Eurlings LW, Bettencourt P, Pimenta JM, Metra M, Bayes-Genis A, Verdiani V, Bettari L, Lazzarini V, Damman P, Tijssen JG, Pinto YM.
    Heart; 2014 Jan 01; 100(2):115-25. PubMed ID: 24179162
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.